Theodore Kapanjie
Family Medicine · Saint Louis, MONPI 1740365980
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.2% of the total across 114 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 14.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,305 and has fallen 87.8% since, to $280 in 2025.
Across 114 payments — averaging $23.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$378
- Lilly USA, LLC$306
- Gilead$263
- AstraZeneca$231
- Novartis$191
- Pfizer$166
- plus $1K from 23 others
What the payments were for
- Food & beverage$2,56096%
- Education$1014%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 8 | $378 |
| Lilly USA, LLC | 12 | $306 |
| Gilead | 9 | $263 |
| AstraZeneca | 13 | $231 |
| Novartis | 7 | $191 |
| Pfizer | 13 | $166 |
| Astellas Pharma US Inc | 3 | $138 |
| Novo Nordisk | 4 | $132 |
| Johnson & Johnson | 2 | $93 |
| Merz North America, Inc. | 2 | $88 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $67 |
| Merck | 4 | $61 |
| Teva Pharmaceuticals USA, Inc. | 4 | $61 |
| Boehringer Ingelheim | 3 | $59 |
| Sanofi-aventis U.S. LLC | 3 | $59 |
| Antares Pharma, Inc. | 4 | $54 |
| GSK | 3 | $51 |
| Esperion Therapeutics, Inc. | 2 | $46 |
| MDD US Operations, LLC | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $26 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $24 |
| Neurocrine Biosciences, Inc. | 1 | $21 |
| Exact Sciences | 1 | $20 |
| Dexcom, Inc. | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Bayer | 1 | $14 |
| Collegium Pharmaceutical, Inc. | 1 | $13 |
| Bausch Health US, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Repatha$297
How this compares
$2,661 in reported general payments places this provider in the 80th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Saint Louis
- Michael DonovanSaint Louis$78K
- Jarad SchwartzSaint Louis$36K
- Christina RobinsSaint Louis$27K
- Michael SpeziaSaint Louis$26K
- David GlickSaint Louis$17K
- Aaron BjornSaint Louis$16K
- Paul RutledgeSaint Louis$16K
- Melissa MurraySaint Louis$15K
- Robert PozziSaint Louis$15K
- Amy MillerSaint Louis$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.